摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5,6-trichloropyridin-2-yl dihydrogen phosphate

中文名称
——
中文别名
——
英文名称
3,5,6-trichloropyridin-2-yl dihydrogen phosphate
英文别名
(3,5,6-Trichloropyridin-2-yl) dihydrogen phosphate
3,5,6-trichloropyridin-2-yl dihydrogen phosphate化学式
CAS
——
化学式
C5H3Cl3NO4P
mdl
——
分子量
278.416
InChiKey
FYFHNBCIPQUYNL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    79.6
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    福司吡酯lead(II) nitrate 作用下, 以 甲醇 为溶剂, 生成 Phosphoric acid methyl ester 3,5,6-trichloro-pyridin-2-yl ester 、 3,5,6-trichloropyridin-2-yl dihydrogen phosphate
    参考文献:
    名称:
    Divalent Metal Ion-Catalyzed Hydrolysis of Phosphorothionate Ester Pesticides and Their Corresponding Oxonates
    摘要:
    The divalent metal ion-catalyzed hydrolysis of thionate (P=S) and oxonate (P=O) organophosphorus pesticides has been examined in light of three possible catalysis mechanisms: (1) metal ion coordination of the thionate sulfur or oxonate oxygen to enhance the electrophilicity of the phosphorus electrophilic site; (2) metal ion coordination and induced deprotonation of water to create a reactive nucleophile; and (3) metal ion coordination of the leaving group to facilitate its exit. The effect of the following metals at a concentration of 1 mM was examined: COII, Ni-II, Cu-II, Zn-II and Pb-II. These metal ions were chosen for their ability to complex organic ligands and inorganic nucleophiles. Of these metal ions, Cu-II possesses properties most suitable for all three catalytic mechanisms and serves as the most effective catalyst for the five thionate esters (chlorpyrifos-methyl, zinophos, diazinon, parathion-methyi, and ronnel) and the two oxonate esters (chlorpyrifos-methyl oxon and paraoxon) included in this study. A decrease in the degree of Cu-II catalysis at high pH arises from solubility limitations. Pb-II nearly matches Cu-II as a catalyst for oxonate esters, but is a less effective catalyst for thionate esters. Catalysis by Co-II, Ni-II, and Zn-II is negligible. Phenolate product analysis indicates that metal catalysis in some instances shifts hydrolysis from alkyl carbon-centered pathways to phosphorus-centered pathways.
    DOI:
    10.1021/es960499q
点击查看最新优质反应信息

文献信息

  • CoFe2O4@TiO2 decorated reduced graphene oxide nanocomposite for photocatalytic degradation of chlorpyrifos
    作者:Vinod Kumar Gupta、Tanju Eren、Necip Atar、Mehmet Lütfi Yola、Cemal Parlak、Hassan Karimi-Maleh
    DOI:10.1016/j.molliq.2015.04.032
    日期:2015.8
    Chlorpyrifos is widely used to control pest insects in residential, agricultural, and commercial applications. Its common use has led to the release of chlorpyrifos into sediments, wastewater and water sources. The presence of chlorpyrifos in wastewaters and water sources may affect ecosystem and human health due to its chronicle toxicity to aquatic organisms. In this study, magnetic recoverable CoFe2O4@TiO2 decorated reduced graphene oxide nanocomposite was prepared and used for investigating the photodegradation of chlorpyrifos. The nanocomposite was characterized by using transmission electron microscopy, X-ray photoelectron spectroscopy, X-ray diffraction and scanning electron microscopy. In photocatalytic degradation of chlorpyrifos experiments, the effect of operating variables such as initial chlorpyrifos concentration, catalyst dosage and contact time was also investigated. The photocatalytic degradation of chlorpyrifos followed the pseudo-first-order kinetic model. The results indicated that the nanocomposite exhibited a high efficient photocatalytic activity on the photodegradation of chlorpyrifos. The nanocomposite was separated from the solution by a magnet and reused after the photodegradation of chlorpyrifos. The recyclable of the nanocomposite is economically significant in the industry. (C) 2015 Elsevier B.V. All rights reserved.
  • CHARACTERIZATION AND ANALYSIS OF THE COMPOSITION AND DYNAMICS OF THE MAMMALIAN RIBOPROTEOME
    申请人:Beth Israel Deaconess Medical Center, Inc.
    公开号:US20150079590A1
    公开(公告)日:2015-03-19
    The present invention relates to methods for identifying compounds that modulate the translation machinery and methods of diagnosing cancer related to deregulation of the translation machinery. In particular, the methods and diagnostic tests include determining an association between one or more targets and one or more components of the riboproteome and treating a subject with cancer by administering a compound that modulates the association between one or more targets and one or more components of the riboproteome.
  • METHODS OF TREATING PROLIFERATIVE DISORDERS WITH MALATE OR DERIVATIVES THEREOF
    申请人:Sukhatme Vikas P.
    公开号:US20150056215A1
    公开(公告)日:2015-02-26
    The present invention relates to methods, compositions, and diagnostic tests for treating and diagnosing proliferative disorders, such as cancel-, that result in dysregulation of malic enzyme 2. In particular, the methods and compositions include monotherapy with malate, or a derivative thereof, as well as combination therapy, such as malate, or a derivative thereof, combined with another therapeutic agent, such as a malic enzyme 2 inhibitor, an antineoplastic agent, a glycolysis inhibitor, an antiangiogenic agent, an immunomodulatory agent, an antibody, or a cytokine.
  • METHOD FOR PREDICTING A SUBJECTS RESPONSE TO SLC MODULATOR THERAPY
    申请人:THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    公开号:US20210254158A1
    公开(公告)日:2021-08-19
    The present invention provides, inter alia, methods for treating or ameliorating the effects of a disorder, such as schizophrenia or bipolar disorder, by increasing or decreasing proline levels. Further provided are methods of predicting and monitoring the clinical response in a patient, and diagnostic systems for identifying a patient likely to benefit from proline modulation.
  • US9931313B2
    申请人:——
    公开号:US9931313B2
    公开(公告)日:2018-04-03
查看更多

同类化合物

(11bR,11''bR)-2,2''-[氧双(亚甲基)]双[4-羟基-4,4''-二氧化物-二萘并[2,1-d:1'',2''-f][1,3,2]二氧磷杂七环 (11aR)-10,11,12,13-四氢-5-羟基-3,7-二-1-萘-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂磷杂八环 鲸蜡基磷酸-鲸蜡基磷酸二乙醇胺 非对称二乙基二(二甲基胺基)焦磷酸酯 雷公藤甲素O-甲基磷酸酯二苄酯 阿扎替派 间苯二酚双[二(2,6-二甲基苯基)磷酸酯] 锌四戊基二(磷酸酯) 银(1+)二苄基磷酸酯 铵4-(2-甲基-2-丁炔基)苯基4-(2-甲基-2-丙基)苯基磷酸酯 铵2-乙基己基磷酸氢酯 铵2,3-二溴丙基磷酸酯 钾二己基磷酸酯 钾二十烷基磷酸酯 钾二乙基磷酸酯 钾[5,7,7-三甲基-2-(1,3,3-三甲基丁基)辛基]磷酸酯 钾2-己基癸基磷酸酯 钴(2+)十三烷基磷酸酯 钡4,4-二乙氧基-2,3-二羟基丁基磷酸酯 钠辛基氢磷酸酯 钠癸基氢磷酸酯 钠异丁基氢磷酸酯 钠二苄基磷酸酯 钠二(2-丁氧乙基)磷酸酯 钠O,O-二乙基磷酰蔷薇l烯酸酯 钠4-氨基苯基氢磷酸酯水合物(1:1:1) 钠3,6,9,12,15-五氧杂二十八碳-1-基氢磷酸酯 钠2-乙氧基乙基磷酸酯 钠2,3-二溴丙基磷酸酯 钙敌畏 钙二钠氟-二氧代-氧代膦烷碳酸盐 钙3,9-二氧代-2,4,8,10-四氧杂-3lambda5,9lambda5-二磷杂螺[5.5]十一烷3,9-二氧化物 野尻霉素6-磷酸酯 酚酞单磷酸酯 酚酞单磷酸环己胺盐 酚酞二磷酸四钠盐 酚酞二磷酸四钠 辛基磷酸酯 辛基二氯膦酸酯 辛基二氯丙基磷酸酯 辛基二丙基磷酸酯 赤藓糖醇4-磷酸酯 螺[环丙烷-1,9-四环[3.3.1.02,4.06,8]壬烷],2-甲基-,(1-alpha-,2-ba-,4-ba-,5-alpha-,6-ba-,8-ba-)-(9CI) 蚜螨特 莽草酸-3-磷酸酯三钠盐 莽草酸-3-磷酸酯 苯酚,2,4-二硝基-,磷酸(酯)氢 苯氨基磷酸二乙酯 苯基二(2,4,6-三甲基苯基)磷酸酯 苯丁酰胺,N-(5-溴-2-吡啶基)-2,4-二甲基-α,γ-二羰基-